Shareholding disclosure

BNP PARIBAS SA

Declared position

8.97%

Threshold

Crossed upwards

Timeline

Published

28.01.2021

Transaction

20.01.2021

Voting rights breakdown

Voting rights acquired8.97%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAL1R00068

Beneficial owner

BNP PARIBAS SA

Declared address

BNP PARIBAS SA, 75009 Paris

La date de restitution del'emprunt de titres a été modifiée au 15 Avril 2021

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

BNP PARIBAS SA

Vifor Pharma AG28.01.2021TAL1R00068

Disclosure summary

BNP PARIBAS SA disclosed a holding in Vifor Pharma AG on the acquisition side, published by SIX Exchange Regulation on 28.01.2021, at 8.97% of voting rights. Notice category: Single shareholder.

Disclosed position

8.97%

Voting rights acquired

Voting rights acquired8.97%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

BNP PARIBAS SA disclosed a holding in Vifor Pharma AG, published on 28.01.2021.

Publication date28.01.2021

Transaction date20.01.2021

Issuing companyVifor Pharma AG

Beneficial ownerBNP PARIBAS SA

Declared addressBNP PARIBAS SA, 75009 Paris

CategorySingle shareholder

Voting rights acquired8.97%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAL1R00068

Conditions

La date de restitution del'emprunt de titres a été modifiée au 15 Avril 2021

Source: SIX Exchange Regulation · Publication date: 28.01.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open